Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Short Description: Onc dx nsclc stg2 no progres
Coverage Code: Carrier judgment
Action Code: No maintenance for this code
Date Added: January 1, 2006
Effective Date: January 1, 2007
Termination Date: